Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.9%

3 terminated/withdrawn out of 38 trials

Success Rate

87.0%

+0.5% vs industry average

Late-Stage Pipeline

32%

12 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

Phase 4
8(28.6%)
Phase 2
8(28.6%)
N/A
5(17.9%)
Phase 3
4(14.3%)
Phase 1
3(10.7%)
28Total
Phase 4(8)
Phase 2(8)
N/A(5)
Phase 3(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (38)

Showing 20 of 38 trials
NCT04564781Recruiting

Predicting BCG Response

Role: collaborator

NCT03193515Recruiting

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Role: collaborator

NCT04413344Phase 1Completed

Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease

Role: lead

NCT06983210Phase 2Recruiting

Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

Role: collaborator

NCT02923648Active Not Recruiting

Lung Obstruction in Adulthood of Prematurely Born (LUNAPRE)

Role: collaborator

NCT02627872Active Not Recruiting

Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT06447532Enrolling By Invitation

Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients

Role: collaborator

NCT06723145Phase 4Recruiting

Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation

Role: lead

NCT06482268Phase 1Recruiting

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

Role: collaborator

NCT00131846Phase 4Completed

Diuretics In the Management of Essential Hypertension (DIME) Study

Role: lead

NCT00304772Phase 4Withdrawn

Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients

Role: lead

NCT00242944Phase 4Completed

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

Role: lead

NCT00733161Phase 4Completed

Effect of Passive Exercise on Systemic Endothelial Function in Elderly Patients With Chronic Heart Failure

Role: lead

NCT04744532Phase 1Unknown

iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Role: lead

NCT05436587Recruiting

Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes

Role: collaborator

NCT01042730Not ApplicableCompleted

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Role: collaborator

NCT01261234Not ApplicableCompleted

Carotid Artery Stenting With Cilostazol Addition for Restenosis

Role: collaborator

NCT04046159Phase 3Unknown

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Role: collaborator

NCT02907229Not ApplicableCompleted

Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms

Role: collaborator

NCT02528006Phase 2Completed

Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges

Role: collaborator